You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Long-Acting Injectable

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Long-acting Injectable Cabotegravir + Rilpivirine

Not yet recruiting
  • Patient Satisfaction
  • +3 more
    • Santiago, Region Metropolitana, Chile
      CICUC
    Apr 18, 2023

    Breakthrough Symptoms With Long-Acting Injectable Medications

    Not yet recruiting
    • Schizophrenia
    • Schizophrenia Relapse
    • Second Generation Long-Acting Injectable Antipsychotic Medications
    • (no location specified)
    Jul 22, 2022

    Schizophrenia Trial in Long Beach, Marlton (Lumateperone Long-Acting Injectable)

    Recruiting
    • Schizophrenia
    • Lumateperone Long-Acting Injectable
    • Long Beach, California
    • +1 more
    Apr 7, 2022

    Human Immunodeficiency Virus, Opioid Use Disorder Trial in Providence (Combined LAI Treatment: Cabenuva and Sublocade)

    Recruiting
    • Human Immunodeficiency Virus
    • Opioid Use Disorder
    • Combined LAI Treatment: Cabenuva and Sublocade
    • Providence, Rhode Island
      Rhode Island Hospital
    Aug 7, 2023

    HIV-1-infection Trial in Worldwide (Once daily CAB tablet + RPV tablet, Long acting CAB injectable + long acting RPV injectable)

    Not yet recruiting
    • HIV-1-infection
    • Once daily CAB tablet + RPV tablet
    • Long acting CAB injectable + long acting RPV injectable
    • Atlanta, Georgia
    • +11 more
    Dec 13, 2022

    HIV Trial in Worldwide (Oral Cabotegravir (CAB), Oral Rilpivirine (RPV), Long-Acting Injectable Cabotegravir (CAB LA))

    Recruiting
    • HIV Infections
    • Oral Cabotegravir (CAB)
    • +4 more
    • La Jolla, California
    • +30 more
    Feb 2, 2023

    HIV Reservoir, Inflammation and Microbiota Footprint of PLWH

    Recruiting
    • HIV Infections
    • Stool sampling
    • Blood plasma collection
    • Marseille, France
      Hôpital Européen Marseille
    Jul 26, 2022

    Schizophrenia Trial (MK-5720, Placebo)

    Not yet recruiting
    • Schizophrenia
    • (no location specified)
    Jul 24, 2023

    Schizophrenia Trial (Brexpiprazole LAI: Dose 1, Brexpiprazole LAI: Dose 2, Brexpiprazole LAI: Dose 3)

    Withdrawn
    • Schizophrenia
    • Brexpiprazole LAI: Dose 1
    • +3 more
    • (no location specified)
    Apr 20, 2022

    Human Immunodeficiency Virus, Treatment, Antiretroviral Therapy Trial in Seattle (TLC-ART)

    Recruiting
    • Human Immunodeficiency Virus
    • +2 more
    • Seattle, Washington
      UW Positve Research, Harborview Medical Center
    May 8, 2023

    Preparing for Pharmacy-based Delivery of Long-acting Injectable

    Recruiting
    • Hiv
      • Auburn, Alabama
      • +3 more
      Jun 10, 2022

      HIV Trial (DTG/3TC, Cabotegravir (CAB) LA, Rilpivirine (RPV) LA)

      Not yet recruiting
      • HIV Infections
      • (no location specified)
      Jun 13, 2023

      Schizophrenia Trial in Miami (Aripiprazole Lauroxil, Computerized cognitive and functional skills training)

      Not yet recruiting
      • Schizophrenia
      • Aripiprazole Lauroxil
      • Computerized cognitive and functional skills training
      • Miami, Florida
        Jackson Memorial Hospital
      Dec 14, 2022

      HIV-1-infection Trial (Cabotegravir/Rilpivirine, Antiretroviral)

      Recruiting
      • HIV-1-infection
      • Kisumu, Kenya
      • +6 more
      Feb 1, 2023

      HIV Trial in Rio De Janeiro (Cabotegravir Injection)

      Not yet recruiting
      • HIV Infections
      • Cabotegravir Injection
      • Rio De Janeiro, Brazil
        Instituto Nacional de Infectologia Evandro Chagas/ FIOCRUZ
      Aug 23, 2022

      Schizophrenia, Antipsychotics, Long-Acting Injection Trial in Korea, Republic of (Abilify maintena)

      Completed
      • Schizophrenia
      • +4 more
      • Abilify maintena
      • Chungju, Chungcheongbuk-do, Korea, Republic of
      • +26 more
      Dec 16, 2021

      HIV Trial in Puerto Rico, United States (Standard of Care (SOC) Oral ART, Oral RPV, Oral CAB)

      Recruiting
      • HIV Infections
      • Standard of Care (SOC) Oral ART
      • +6 more
      • Birmingham, Alabama
      • +34 more
      Dec 1, 2021

      Osteoarthritis, Knee Trial in Victoria, London (EP-104IAR, Vehicle)

      Completed
      • Osteoarthritis, Knee
      • Victoria, British Columbia, Canada
      • +2 more
      Aug 30, 2021

      Bunion Trial in Salt Lake City (Local anesthetic injection of CPL-01, Naropin, 0.5% Injectable Solution, Placebo)

      Not yet recruiting
      • Bunion
      • Local anesthetic injection of CPL-01
      • +2 more
      • Salt Lake City, Utah
        Todd Bertoch
      Apr 25, 2023

      Hiv Trial in United States (Self-guided health education, Patient-provider decision tool, Provider-guided education)

      Not yet recruiting
      • Hiv
      • Self-guided health education
      • +2 more
      • Bronx, New York
      • +5 more
      Apr 17, 2023

      Implementation and Delivery of Cabotegravir Long Acting

      Not yet recruiting
      • HIV Infections
      • Cabotegravir Injection [Apretude]
      • Seattle, Washington
      • +1 more
      May 16, 2023

      Human Immunodeficiency Virus Type 1 (HIV-1) Trial in Worldwide (Cabotegravir - Injectable Suspension (CAB LA), Rilpivirine -

      Active, not recruiting
      • Human Immunodeficiency Virus Type 1 (HIV-1)
      • Cabotegravir - Injectable Suspension (CAB LA)
      • Rilpivirine - Injectable Suspension (RPV LA)
      • Macon, Georgia
      • +29 more
      May 31, 2023

      HIV Trial (Tenofovir disoproxil fumarate/emtricitabine (TDF-FTC), cabotegravir (CAB-LA), Cabotegravir (CAB-LA), Tenofovir

      Not yet recruiting
      • HIV
      • Tenofovir disoproxil fumarate/emtricitabine (TDF-FTC), cabotegravir (CAB-LA)
      • Cabotegravir (CAB-LA), Tenofovir disoproxil fumarate/emtricitabine (TDF-FTC)
      • (no location specified)
      Nov 13, 2023

      HIV Trial in Worldwide (GSK1265744 Tablets, Injectable GSK1265744, Placebo for GSK1265744 Tablets)

      Completed
      Has Results
      • HIV Infections
      • GSK1265744 Tablets
      • +3 more
      • Los Angeles, California
      • +7 more
      Oct 14, 2021

      Human Immunodeficiency Virus Type 1 (HIV-1) Trial in Worldwide (Cabotegravir Injectable Suspension, Rilpivirine Injectable

      Completed
      • Human Immunodeficiency Virus Type 1 (HIV-1)
      • Cabotegravir Injectable Suspension
      • Rilpivirine Injectable Suspension
      • Bakersfield, California
      • +31 more
      May 31, 2023